TELA Bio, Inc. - Class A Common Stock (TELA)

CUSIP: 872381108

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
-256,374
Put/Call ratio
650%
SEC-reported price per share
$5.67
Number of holders
58
Value change
-$1,655,166
Number of buys
29
Open additional details 1 more signal available
Number of sells
29
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
44,525,021

Security key

872381108

Report period

Q1 2024

Institutions

58

Top holders

10

Ownership snapshot

Top reported holders of TELA - TELA Bio, Inc. - Class A Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Essex Woodlands Managemen...
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5 13F Highest disclosed value: $27,212,894 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Essex Woodlands Management, Inc. has the largest disclosed position value at $27.21M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Essex Woodlands Management, Inc.'s linked filing trail.
Disclosed position value Top 5
Opaleye Management Inc. $11.71M
Essex Woodlands Management, Inc. $27.21M
ORBIMED ADVISORS LLC $18.77M
First Light Asset Management, LLC $16.91M
AIGH Capital Management LLC $9.12M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Opaleye Management Inc.
3/4/5
Former 10% Owner.
—
denominator unverified
$11,710,150
2,072,813 shares
— 20 Apr 2023
Essex Woodlands Management, Inc.
13F
Company
13F
—
denominator unverified
$27,212,894
4,110,709 shares
— 31 Dec 2023
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$18,771,288
2,835,542 shares
— 31 Dec 2023
First Light Asset Management, LLC
13F
Company
13F
—
denominator unverified
$16,911,723
2,554,641 shares
— 31 Dec 2023
AIGH Capital Management LLC
13F
Company
13F
—
denominator unverified
$9,121,996
1,377,945 shares
— 31 Dec 2023
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$7,267,873
1,097,866 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
58
Shares
20,686,484
Rows available
58
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
58
Q1 2024 holders
58
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .